Policies to Impact

GHIAA is a global resource providing research, education, advocacy and support to stakeholders involved with global health agreements and related policies. Click below to access the GHIAA MAPGuide, a curated collection of actual and template contractual provisions from global health alliance agreements.

The Global Healthcare Innovation Alliance Accelerator (GHIAA)

We are dedicated to improving the health of the world’s communities through accelerated and improved alliance formation.

The  Global Healthcare Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

global_healt_rep_david_price510 (1)

The  Global Healthcare Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

global_healt_rep_david_price510 (1)
global_healt_rep_david_price510 (1)

The  Global Healthcare Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

Launch of the MAPGuide

We are excited to announce the launch of the GHIAA Master Alliance Provisions Guide (MAPGuide). The MAPGuide is a new tool to help practitioners and policymakers access a curated collection of actual and template contractual provisions from global health agreements that address key principles upon which partnerships are built. The MAPGuide will be updated regularly, and we are seeking additional content in the form of full agreements or individual agreement provisions.

Latest News

  • May 26, 2022

    New Article in Think Global Health: Building COVID-19 Vaccine Production Capacity in LMICs

    Authors Reid Adler, Julia Barnes-Weise, Ana Santos Rutschman, and Bridie Telford have published a new article in Think Global Health exploring the potential obstacles created by vaccine patents. The piece includes a table listing the LMICs in which there are active patent filings for the 13 vaccines tracked in VaxPaL, the Medicines Patent Pool on-line database of information on the patent status of COVID-19 vaccines worldwide. Read More
  • March 31, 2022

    MAPGuide Featured in New "Inventory of COVID-19 Information Resources"

    Compiled by the World Trade Organization, this resource provides information on a variety of topics, such as vaccination, production of vaccines, government procurement, cases, diagnostics, therapeutics and intellectual property-related issues from NGOs, IGOS, academics, nonprofits, and the private sector. The inventory will be updated as new resources become available. Access the Inventory
  • March 18, 2022

    GHIAA Participates in Vaccine Equity Conference with Columbia University

    On Wednesday, March 30 at 12pm EST, GHIAA Executive Director Julie Barnes-Weise will participate in a roundtable discussion titled "Vaccine Equity Distribution Capacity-Building in terms of IP, Technology and Talent Transfer, and Manufacturing." The roundtable is part of a 4-day symposium on Covid-19 vaccines hosted by the Columbia University Irving Medical Center. This symposium is free and virtual, with registration required. Register Here
  • February 25, 2022

    Panel Participation

    The global intellectual property framework has been instrumental to developing Covid vaccines, with billions of doses now made every month. Following our recent paper assessing the proposed intellectual property waiver as a mechanism to address COVID-19 vaccine scarcity, GHIAA Executive Director, Julie Barnes-Weise will participate in a panel hosted by the Geneva Network on March 2. Register Here